Decibel Therapeutics Inc (NASDAQ:DBTX)
| 2.06 Delayed Data As of May 13 |  +0.02 / +0.97%Today’s Change | 1.83 Today|||52-Week Range 9.75 | -55.70% Year-to-Date |
Latest DBTX News | Press Releases
No recent news for Decibel Therapeutics Inc.
Today’s Trading
| Previous close | 2.07 |
| Today’s open | 2.23 |
| Day’s range | 2.06 - 2.26 |
| Volume | 78,739 |
| Average volume (3 months) | 64,000 |
| Market cap | $52.2M |
Data as of 4:00pm ET, 05/13/2022
Growth & Valuation
| Earnings growth (last year) | -976.70% |
| Earnings growth (this year) | +23.87% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.37 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.58 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$51.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
